Senate Aging Committee Hearing on Drug Prices: Faster Generics Approval Could Cut Drug Costs

Conclusion As Senator Tom Tillis reminded his colleagues, it is important to not "cast all pharmaceutical companies in the same light," but instead focus on the few pharmaceutical companies acting as "hedge funds." There were many senators in attendance at the hearing, and many who went over their five-minute time allotment in asking questions of the witnesses. This committee in particular seems to have a laser-focus on the high cost of prescription drugs, and it is likely we will see some bills or other action from senators on the committee in the coming months. The good news is, the senators all seem to be interested in going after the problem companies while allowing most pharmaceutical companies to continue their honorable work of finding new cures for diseases and medicines to make Americans lives easier.       Related StoriesSenators McCain and Grassley Request HHS for Approval of Importation of Certain DrugsSenate Finance Committee Releases Results of Investigation Into Gilead’s Pricing Strategy for Hepatitis-C DrugsDrug Pricing Forums and Congressional Actions 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs